Main results
Four RCTs were identified: three comparing 2 g of preoperative amoxicillin versus placebo (927 patients) and the other comparing 1 g of preoperative amoxicillin plus 500 mg 4 times a day for 2 days versus no antibiotics (80 patients). The meta-analyses of the four trials showed a statistically significant higher number of patients experiencing implant failures in the group not receiving antibiotics: RR = 0.40 (95% CI 0.19 to 0.84). The number needed to treat (NNT) to prevent one patient having an implant failure is 33 (95% CI 17 to 100), based on a patient implant failure rate of 5% in patients not receiving antibiotics. The other outcomes were not statistically significant, and only two minor adverse events were recorded, one in the placebo group.
Authors' conclusions
There is some evidence suggesting that 2 g of amoxicillin given orally 1 hour preoperatively significantly reduce failures of dental implants placed in ordinary conditions. No significant adverse events were reported. It might be sensible to suggest the use of a single dose of 2 g prophylactic amoxicillin prior to dental implant placement. It is still unknown whether postoperative antibiotics are beneficial, and which is the most effective antibiotic.
P L A I N L A N G U A G E S U M M A R Y

Interventions for replacing missing teeth: antibiotics at dental implant placement to prevent complications
Missing teeth can sometimes be replaced with dental implants to which a crown, bridge or denture can be attached. Bacteria introduced during placement of implants can lead to infection and sometimes implant failure. It appears that the oral administration of 2 grams of amoxicillin 1 hour before placement of dental implants is effective in reducing implant failures. More specifically, giving antibiotics to 33 patients will avoid one patient experiencing early implant losses. It is still unclear whether postoperative antibiotics are of any additional benefits. 
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Antibiotics compared with no antibiotics at placement of dental implants *The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI = confidence interval RR = risk ratio GRADE Working Group grades of evidence:
High quality (++++): Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality (+++O):
Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality (++OO):
Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality (+OOO):
We are very uncertain about the estimate.
B A C K G R O U N D
Dental implants are widely used for replacing missing teeth. Despite the high success rates published in the literature, implant failures do occur (Esposito 1998a). It is believed that a certain number of early dental implant losses are due to bacterial contamination at implant insertion (Esposito 1998b). It is known that infections around biomaterials are very difficult to treat and almost all infected implants have to be removed sooner or later (Esposito 1998b) . The likelihood of an infection around dental implants is influenced by the surgical skill (traumatic and prolonged surgery is more likely to favour infections) and by the degree of asepsis.
In general, antibiotic prophylaxis in surgery is only indicated in the following situations: patients at risk of infectious endocarditis, patients with reduced host-response, when surgery is performed in infected sites, in cases of extensive and prolonged surgical interventions and when large foreign materials are implanted.
In order to minimise infections after dental implant placement various prophylactic systemic antibiotic regimens have been suggested. Initially, antibiotics were recommended preoperatively and up to 10 days postoperatively, one of the most commonly followed protocols being the administration of 2 g of phenoxymethylpenicillin (penicillin-V), orally, about 1 hour preoperatively and then 2 g twice a day for 10 days (Adell 1985). More recent protocols (Flemmig 1990) recommended short term prophylaxis: 2 g of penicillin-V (or amoxicillin or amoxicillin/clavulanate) administered orally, 1 hour prior to surgery and 500 mg of penicillin-V 4 times a day for 1 day. The prolongation of the prophylaxis should not be extended beyond the first 3 postoperative days since it may not provide additional protection.
While on one hand it is important to minimise risk of implant failures, on the other it is sensible to minimise the use of antibiotics since adverse events may occur. Complications most commonly associated with the use of antibiotics range from diarrhoea to lifethreatening allergic reactions. Another major concern associated with the widespread use of antibiotics is the selection of antibioticresistant bacteria.
The use of antibiotics in implant dentistry is controversial and some controlled clinical trials (CCTs) yielded contradictory results (Dent 1997; Gynther 1998; Laskin 2000; Binahmed 2005). The first study on this subject (Dent 1997) evaluated implant success at abutment connection (4 to 6 months after implant placement) comparing various dosages and various antibiotics given preoperatively and postoperatively, in most of the cases, versus no antibiotics or antibiotics given with an insufficient dosage in an unknown number of patients (2641 implants). Significantly fewer failures occurred in the antibiotic group (1.5% versus 4%). The study was updated by a second publication (Laskin 2000) that presented data with a follow up of 3 years after loading. There were 387 patients (1743 implants) in the antibiotic groups and 315 patients (1247 implants) in the control group. The results suggested fewer failures when antibiotics were used (4.6% versus 10%). This multicentre trial was initially described as a randomised controlled trial (RCT), but in reality dentists were free to choose when to give antibiotics, which antibiotics to give, and which dosage to use. In addition, there was no blind assessment and patients were not considered the statistical unit of the analysis, so the possible clustering of failures was not taken into account. In a retrospective controlled clinical study (Gynther 1998), 147 patients (790 implants) who received 1 g of phenoxymethylpenicillin 1 hour preoperatively and 1 g every 8 hours postoperatively for 10 days were compared with 132 patients (664 implants) who did not receive any antibiotics. Both groups were treated at the same centre but at different time points (antibiotic group between 1980 and 1985; no antibiotic group between 1991 and 1995). No differences in survival rates were reported. In another prospective multicentre controlled clinical study (Binahmed 2005) , the comparison was of a single preoperative dose of penicillin G or V (1,000,000 units) or 600 mg of clindamycin versus an identical preoperative dose plus 300 mg penicillin V orally 4 times a day, or in case of penicillin allergy, 150 mg clindamycin orally 3 times a day for 7 days. A single dose was given to 125 patients (445 implants) whereas long term prophylactic antibiotics were given to 90 patients (302 implants).
Only biological complications were evaluated at 1, 2 weeks and just before abutment connection. There were no differences regarding biological complications: three wound dehiscences in each group, one developing an infection in the long term antibiotic group. The authors concluded that long term prophylactic antibiotic use was of no advantage or benefit over a single dose, however implant success, which should have been the primary outcome measure, was not evaluated. Unfortunately, all these studies were highly biased in their methodology, so the validity of their conclusions can be questioned. A recent systematic review on this topic concluded that there is little evidence for the use of antibiotic prophylaxis in general dentistry and recommended to monitor antibiotic use among dental practitioners (Schwartz 2007). It would be useful to know whether prophylactic antibiotics are effective in reducing postoperative infections and failures of dental implants and which is the most effective antibiotic, at what dose and duration.
O B J E C T I V E S Primary objective
To test the null hypothesis of no difference in the proportion of prosthesis failures, implant failures, postoperative infections and adverse events between patients receiving antibiotic prophylaxis, and those receiving a placebo or no antibiotic, at placement of dental implants, against the alternative hypothesis of a difference. To test the null hypothesis of no difference in the proportion of prosthesis failures, implant failures, postoperative infections and adverse events between groups of patients receiving different prophylactic antibiotics, or different doses/duration of the same antibiotic, against the alternative hypothesis of a difference.
Secondary objective
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled clinical trials (RCTs) with a follow-up of at least 3 months.
Types of participants
Any group of patients undergoing dental implant placement.
Types of interventions
• Administration of prophylactic antibiotics versus no antibiotics/placebo.
• Administration of different antibiotics.
• Administration of different doses or different duration of the same antibiotic.
Types of outcome measures Primary outcomes
• Implant failure: implant mobility and removal of stable implants dictated by progressive marginal bone loss or infection.
• Prosthesis that could not be placed or prosthesis failure if secondary to implant failures.
Secondary outcomes
• Postoperative infections.
• Adverse events (gastrointestinal, hypersensitivity, etc).
Search methods for identification of studies
For the identification of studies included or considered for this review, detailed search strategies were developed for each database searched. These were based on the search strategy developed for MEDLINE (OVID) but revised appropriately for each database. 
Language
There were no language restrictions.
Unpublished studies
We wrote to all the authors of the identified RCTs, we checked the bibliographies of all identified RCTs and relevant review articles, and we used personal contacts in an attempt to identify unpublished or ongoing RCTs. In the first version of this review we also wrote to more than 55 oral implant manufacturers and we requested information on trials through an Internet discussion group (implantology@yahoogroups.com), however we discontinued this due to poor yield. 
Handsearching
Data collection and analysis
Study selection
The titles and abstracts (when available) of all reports identified through the electronic searches were scanned independently by two review authors. For studies appearing to meet the inclusion criteria, or for which there were insufficient data in the title and abstract to make a clear decision, the full report was obtained. The full reports obtained from all the electronic and other methods of searching were assessed independently by two review authors to establish whether the studies met the inclusion criteria or not. Disagreements were resolved by discussion. Where resolution was not possible, a third review author was consulted. All studies meeting the inclusion criteria then underwent validity assessment and data extraction. Studies rejected at this or subsequent stages were recorded in the table of excluded studies, and reasons for exclusion recorded.
Data extraction
Data were extracted by two review authors independently using specially designed data extraction forms. The data extraction forms were piloted on several papers and modified as required before use. Any disagreement was discussed and a third review author consulted where necessary. All authors were contacted for clarification or missing information. For each trial the following data were recorded.
• Year of publication, country of origin and source of study funding.
• Details of the participants including demographic characteristics, source of recruitment and criteria for inclusion.
• Details of the type of intervention.
• Details of the outcomes reported, including method of assessment, and time intervals.
Measure of treatment effect
For each outcome, all of which were binary, the estimate of effect of an intervention was expressed as risk ratios together with 95% confidence intervals.
Unit of analysis issues
The statistical unit was the patient and not the prosthesis or implant.
Dealing with missing data
Trial authors were contacted to retrieve missing data where necessary. Data were excluded until further clarification was available if agreement could not be reached. Methods for estimating missing standard deviations in section 7.7.3 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2009) will be used. An ITT analysis was undertaken if data available and appropriate.
Assessment of heterogeneity
The significance of any discrepancies in the estimates of the treatment effects from the different trials was to be assessed by means of Cochran's test for heterogeneity and heterogeneity would have been considered significant if P < 0.1. The I 2 statistic, which describes the percentage total variation across studies that is due to heterogeneity rather than chance, was used to quantify heterogeneity with I 2 over 50% being considered moderate to high heterogeneity.
Assessment of reporting biases
If there had been sufficient numbers of trials (more than 10) in any meta-analysis publication bias would have been assessed according to the recommendations on testing for funnel plot asymmetry (Egger 1997) as described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2009). If asymmetry was identified we would have examined possible causes.
Data synthesis
Only if there were studies of similar comparisons reporting the same outcome measures a meta-analysis was done. Risk ratios were combined for dichotomous data, using random-effects models provided there were more than 3 studies in the meta-analysis. Numbers needed to treat (NNT) were calculated for patients affected by implant failures. The Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2009) recommendations were followed for studies with zero-cell counts. The fixed value of 0.5 was added to all cells with zero-cell counts and risk ratios calculated with the RevMan software. If there were no events in both arms, no calculations were undertaken because in this situation the study does not provide any indication of the direction or magnitude of the relative treatment effect.
Subgroup analysis and investigation of heterogeneity
Clinical heterogeneity was to be assessed by examining the types of participants and interventions for all outcomes in each study. It was decided to formulate the following hypotheses to be investigated for subgroup analyses. However since the number of trials included in the meta-analysis was small (less than 10) this was not undertaken. This may be done in future updates of this review for the following subgroups: • Single vs multiple implants.
• Postextractive implants vs implants in completely or partially healed sites.
• Long vs short procedures.
• Complicated versus simple procedures.
Sensitivity analyses
It was planned to undertake sensitivity analyses to examine the effect of the study quality assessment on the overall estimates of effect. In addition, the effect of including unpublished literature on the review's findings was also to be examined. There were too few trials to undertake these analyses.
Assessment of risk of bias in included studies
This was conducted using the recommended approach for assessing risk of bias in studies included in Cochrane reviews (Higgins 2009). It is a two-part tool, addressing the six specific domains (namely sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and 'other issues'). Each domain includes one specific entry in a 'Risk of bias' table. Within each entry, the first part of the tool involves describing what was reported to have happened in the study. The second part of the tool involves assigning a judgement relating to the risk of bias for that entry. This is achieved by answering a prespecified question about the adequacy of the study in relation to the entry, such that a judgement of 'Yes' indicates low risk of bias, 'No' indicates high risk of bias, and 'Unclear' indicates unclear or unknown risk of bias. The risk of bias assessment of the included trials was undertaken independently and in duplicate by two review authors as part of the data extraction process. In the case that the paper to be assessed had one or more review authors in the authors list, it was independently evaluated only by those review authors not involved in the trials.
Summarising risk of bias for a study:
After taking into account the additional information provided by the authors of the trials, studies were grouped into the following categories. We assumed that the risk of bias was the same for all outcomes and each study was assessed as follows:
Risk of bias Interpretation Within a study Across studies
Low risk of bias. Plausible bias unlikely to seriously alter the results.
Low risk of bias for all key domains. Most information is from studies at low risk of bias.
Unclear risk of bias. Plausible bias that raises some doubt about the results.
Unclear risk of bias for one or more key domains.
Most information is from studies at low or unclear risk of bias High risk of bias. Plausible bias that seriously weakens confidence in the results
High risk of bias for one or more key domains.
The proportion of information from studies at high risk of bias is sufficient to affect the interpretation of results 
R E S U L T S Description of studies
Interventions
The following hypotheses were tested.
(1) Whether prophylactic antibiotics are effective in reducing failures and complications (four trials with 1007 patients).
• One trial (Abu-Ta'a 2008) compared 1 g of amoxicillin given 1 hour preoperatively plus 500 mg of amoxicillin 4 times a day for 2 days versus no antibiotics. All patients rinsed with chlorhexidine digluconate for 1 minute just prior to surgery and postoperatively twice a day for 7 to 10 days. The perioral skin was disinfected for 30 seconds with cetrimonium bromide 0.5 and chlorhexidine 0.05 in water. Measures of asepsis included use of sterile drapes around the patient's mouth, head, and over the supine body of the patient, a meshed nose guard, and two suction tips (one only for the mouth and one only for the wound). Postoperative complications were assessed at 7 to 10 days and implant success at 5 months. An unknown type of dental implant was used.
• Two placebo-controlled trials (Esposito 2008a; Esposito 2010) compared 2 g of amoxicillin given 1 hour preoperatively with identical placebo tablets. One week prior to implant placement, all patients underwent at least one session of oral hygiene instruction and professionally delivered debridement when required. All patients rinsed with chlorhexidine digluconate for 1 minute just prior to surgery and postoperatively twice a day for at least 1 week. Operators were allowed to place and restore the implants according to their routine procedures. Postoperative complications were assessed at 1 and 2 weeks, and implant success at 4 months. Various implant systems brands were used (Zimmer Dental, Dentsply Friadent, Nobel Biocare, Intra-Lock, Camlog, Dyna, Biomet 3i, Endopore, Z-system, PF Tecom, Ghimas, Silpo, MegaGen and Geass).
• One placebo-controlled trial (Anitua 2009) compared 2 g of amoxicillin given 1 hour preoperatively with identical placebo tablets. Patients received, during the days prior to the intervention, appropriate prophylaxis and adequate oral hygiene instructions. Antibiotics and other medications were not allowed 15 days before the surgery. All patients rinsed with 2% chlorhexidine digluconate for 1 minute just prior to surgery. Only single implants in medium bone quality were included and all implants were inserted after flap elevation. Before installation, implants were carefully humidified with liquid plasma rich in growth factors (PRGF). Peripheral blood (20 to 30 ml) from each patient was taken by venipuncture before surgery and placed directly into 9 ml tubes containing 3.8% (wt/vol) sodium citrate as anticoagulant. Liquid PRGF was prepared by centrifugation (PRGF System®, BTI) at 460 × g for 8 minutes at room temperature. 1 ml plasma fraction was collected and deposited in a glass dish. In order to initiate clotting, PRGF activator (calcium chloride) was added to the liquid PRGF preparation (50 µl PRGF activator per ml of preparation).
Postoperative infections were assessed at days 3, 10, 30 and 60. Implant stability was also evaluated at month 3 using Osstell. BTI dental implants were used.
(2) Which is the most effective antibiotic, dose and duration (no trials).
Outcomes
All trials reported all the outcome measures under investigation in the present review: • Five months after implant placement (Abu-Ta'a 2008).
Main inclusion criteria
• Any patient older than 18 years old, able to sign an informed consent, undergoing dental implant placement (Esposito 2008a; Esposito 2010).
• Patients requiring single implants in bone of medium density. Bone density was measured in Hounsfields (HU) on high resolution scans with the BTI Scan® program (BTI, Vitoria, Spain). Medium bone density was defined as from 400 to 1100 HU (Anitua 2009).
• Fully or partially edentulous patients (Abu-Ta'a 2008).
Main exclusion criteria
• At risk of bacterial endocarditis (Abu-Ta'a 2008; Esposito 2008a; Esposito 2010).
• Having implanted biomaterials in the body (hip or knee prostheses, etc) (Esposito 2008a; Esposito 2010).
• Immunosuppressed or immunocompromised (Abu-Ta'a 2008; Esposito 2008a; Esposito 2010).
• Affected by diabetes (controlled or uncontrolled) (Esposito 2008a; Esposito 2010).
• Uncontrolled diabetes mellitus (Abu-Ta'a 2008). • Need of augmentation procedure concomitant with implant placement (Esposito 2008a; Esposito 2010).
•
• Presence of chronic/acute infections in the vicinity of the planned implant site (Esposito 2008a; Esposito 2010).
• 
Risk of bias in included studies
The final risk of bias assessment after having incorporated the additional information kindly provided by the author of one trial (Abu-Ta'a 2008) is summarised in Figure 1 
Effects of interventions
See: Summary of findings for the main comparison
• One trial (Abu-Ta'a 2008) compared 1 g of amoxicillin given 1 hour preoperatively plus 500 mg of amoxicillin 4 times a day for 2 days versus no antibiotics. Forty patients were included in each group and none dropped out after 5 months. No prosthesis failed. Five implants failed in three patients who did not receive antibiotics. One patient in the antibiotic group and four patients in the control group experienced a postoperative infection. No adverse events were reported. No statistically significant differences were observed for any of the outcome measures.
• One placebo-controlled trial (Esposito 2008a) compared 2 g of amoxicillin given 1 hour preoperatively with identical placebo tablets. One hundred and sixty-five patients were included in each group, but seven patients from each group had to be excluded from the analyses for various reasons. Two patients in the antibiotic group experienced a prosthesis failure versus four patients in the placebo group. Two patients (two implants) in the antibiotic group experienced implant losses versus eight patients (nine implants) in the placebo group. Three patients in the antibiotic group presented sign of infection versus two patients in the placebo group. One minor adverse event was recorded in each group. No statistically significant differences were observed for any of the outcome measures.
E d u c a t i o n a l P u r p o s e s -N o t t o b e R e p u b l i s h e d E d u c a t i o n a l P u r p o s e s -N o t t o b e R e p u b l i s h e d
• One placebo-controlled trial (Anitua 2009) compared 2 g of amoxicillin given 1 hour preoperatively with identical placebo tablets. Fifty-two patients were included in the antibiotic group and 53 in the placebo group. Two patients in each group experienced an implant/crown failure and six patients in each group experienced a postoperative infection. No adverse events were reported. No statistically significant differences were observed for any of the outcome measures.
• One placebo-controlled trial (Esposito 2010) compared 2 g of amoxicillin given 1 hour preoperatively with identical placebo tablets. Two hundred and fifty-four patients were included in the antibiotic group and 255 in the placebo group, but two patients from the antibiotic group and one from the placebo group had to be excluded from the analyses for various reasons. Four patients in the antibiotic group experienced a prosthesis failure versus 10 patients in the placebo group. Five patients in the antibiotic group experienced seven implant losses versus 12 patients that lost 13 implants in the placebo group. Four patients in the antibiotic group presented clear signs of infection versus eight patients in the placebo group. No adverse events were reported. No statistically significant differences were observed for any of the outcome measures.
In total 1007 patients were included in the four trials. More patients experienced implant losses in the group that did not receive antibiotics and this was statistically significant (Figure 3 ) risk ratio (RR) 0.40, 95% confidence interval (CI) 0.19 to 0.84. In order to illustrate the magnitude of the effect of implant failures, the number of patients needed to treat (NNT), i.e. given antibiotics, to prevent one patient having an implant failure is 33 (95% CI 17 to 100). This is based on a patient implant failure of 5% in patients not receiving antibiotics, as seen in the meta-analysis. No heterogeneity was observed in the meta-analysis (P = 0.62; I² = 0%). The meta-analyses of the four trials for the other outcomes showed no statistically significant differences for prosthesis failures (Analysis 1.2), postoperative infections (Analysis 1.3), and adverse events (Analysis 1.4). 
D I S C U S S I O N
The meta-analysis of four randomised controlled trials (RCTs) suggests that short term antibiotics (2 g of amoxicillin administered 1 hour prior to implant placement (Esposito 2008a; Anitua 2009; Esposito 2010) or 1 g of amoxicillin administered 1 hour prior to implant placement and 500 mg 4 times a day for 2 days postoperatively (Abu-Ta'a 2008)) significantly decrease early implant failures. This observation has important clinical implications, meaning that antibiotics would prevent one patient experiencing an early implant loss every 33 patients receiving antibiotics. Only two minor adverse events were reported, one in the antibiotic group (diarrhoea and somnolence) and one in the placebo group (itching for 1 day), which suggest that the antibiotic regimens used may not have a tremendous negative impact on the patients' wellbeing. In other words the benefit of using short term antibiotics may outweigh the risks in the short term for individual patients.
All included trials appeared to be underpowered to detect a clinically significant difference, even though they showed clear trends favouring antibiotics. A statistically and clinically significant difference in implant failures was found after the meta-analyses. This underscores the importance of meta-analyses to increase sample size of individual trials to reach more precise estimates of the ef- In fact, only patients receiving single implants in medium bone quality were included. It is possible that there is no benefit of using antibiotic prophylaxis when performing simple implant placement procedures in patients having ideal bone conditions. Therefore, dentists have to decide whether to provide or not prophylactic antibiotic cover according to the complexity of the placement procedure. On the other hand, it may not always be possible to predict with certainty how simple a surgical procedure could be.
While the efficacy of antibiotics in reducing early implant losses was evident, no apparent significant effects of antibiotics on the occurrence of postoperative infections were observed. A possible explanation is that asymptomatic infections could have determined the loss of some implants. The histocompatability of the peri-implant tissues without apparent clinical sign of infection observed in a consecutive series of early failed implants was compatible with an asymptomatic infection failure modality (Esposito 1999).
In two trials (Esposito 2008a; Esposito 2010) it was decided not to include patients undergoing bone augmentation procedures concurrent to implant placement because it was known that patients could have undergone unnecessary risks of infections. This was based on the findings of a pilot placebo-controlled RCT (Lindeboom 2003) comparing a preoperative single dose of 2 g penicillin phenethicillin with a placebo in 20 patients undergoing intraoral buccal onlay grafting with resorbable barriers to allow implant placement (the implants were not placed in the study). Two patients developed an infection at both the receptor and donor sites; two patients developed a wound infection at the receptor site; and one patient developed an infection at the donor site only. All of these patients (50%) were in the placebo group. No infections were observed in the antibiotic group. It could be concluded that there was a statistically significant increased risk of having an infectious complication after bone augmentation with resorbable barriers without antibiotic prophylaxis.
Additional information can be obtained from two double-blinded RCTs evaluating the efficacy of prophylactic antibiotics used for bone augmentation procedures prior to implant placement Seventy-five patients were included in each group and the presence of infection was assessed weekly for 8 weeks. No statistically significant differences were observed for postoperative infections (four infections at the augmented sites of the penicillin phenethicillin versus two in the clindamycin group, and three infections at the donor site of each group). The findings of this trial suggest that both penicillins and clindamycin are effective in reducing infection at augmented sites. No side effects related to the singleadministration of antibiotics were reported. The same group in another similar RCT (Lindeboom 2005) evaluated whether it was more effective to use a single dose of 600 mg clindamycin 1 hour prior to onlay bone grafting procedures followed by either placebo or 300 mg clindamycin every 6 hours for 1 day. Sixty-two patients were included in each group. No statistically significant differences were observed for postoperative infections (two infections at the augmented sites of the single dose group versus three infections in the 1 day group, and four infections at the donor sites of the single dose group versus two infections in the 1 day group). Again no side effects related to the administration of antibiotics were reported.
There are public health concerns regarding prolonged antibiotics usage, however we were unable to find any evidence suggesting that a single dose of 2 g of amoxicillin was associated with a significant selection of antibiotic-resistant bacteria, nor did the included trials suggest a significant occurrence of adverse events. In addition no statistically significant alterations in microflora composition were observed in one trial (Anitua 2009) where a preoperative and a 3-day postoperative microbiological evaluation was performed.
A U T H O R S ' C O N C L U S I O N S Implications for practice
There is evidence from a meta-analysis including four trials with 1007 patients suggesting that 2 g of amoxicillin given orally 1 hour preoperatively significantly reduce early failures of dental implants placed in ordinary conditions. More specifically, giving antibiotics to 33 patients will avoid one patient experiencing early implant losses. No statistically significant differences in postoperative infections and adverse events were observed. No major adverse events were reported. It might be sensible to suggest a routine use of a single dose of 2 g of prophylactic amoxicillin just before placing dental implants. It remains unclear whether an adjunctive use of postoperative antibiotics is beneficial, and which is the most effective antibiotic. 
Implications for research
Priority should be given to large pragmatic double-blinded RCTs evaluating the efficacy of prolonged antibiotic prophylaxis when compared to a single preoperative dose into those subgroups of patients where implant failures are more likely to occur, particularly in those patients receiving immediate post-extractive implants and augmentation procedures in conjunction with implant placement. It could be also useful to evaluate which could be the most effective antibiotic type. Interventions 1 g of amoxicillin given 1 hour preoperatively plus 500 mg of amoxicillin 4 times a day for 2 days versus no antibiotics. Unknown type of dental implants Outcomes Implant failures, postoperative infections, adverse events, microbiological evaluation. Postoperative infections were assessed 7 to 10 days after placement, and implant success at 5 months
Notes
Risk of bias
Item
Authors' judgement Description
Adequate sequence generation? Yes Quoted from the article: "These patients were randomly assigned into one of two groups (with and without antibiotics = AB) of 40 patients each using random sampling with masking of the person performing the randomization." Author's replay: "After verification of the inclusion criteria, 80 patients were enrolled into the study. All patients were assigned a patient number, and were randomly assigned to one of the two treatment regimens. Assignment was performed by one of our department's nurses using a randomization 
Anitua 2009
Methods Parallel RCT of 3 months duration. No drop outs.
Participants
Only patients needing single implants in medium bone quality were included and all implants were inserted after flap elevation. Adults treated in 8 private Spanish dental practices. Patients were excluded if they were allergic to beta-lactam antibiotics, had concurrent local or systemic infections requiring antibiotic treatment, had systemic diseases that contraindicate the surgery including cardiovascular diseases, respiratory diseases, haematological and metabolic disorders, bone diseases, collagenosis, immunodeficiencies and renal insufficiency, received irradiation to the head and neck (> 5000 rads). 52 patients included in the antibiotic group and 53 in the placebo group and results given for 52 and 53 patients, respectively Interventions 2 g of amoxicillin given 1 hour preoperatively compared with identical placebo tablets. Before installation, implants were carefully humidified with liquid plasma rich in growth factors (PRGF). Postoperative infections were assessed at days 3, 10, 30 and 60. At month 3 also implant stability was evaluated using Osstell. BTI dental implants were used Outcomes Implant failures (assessed with Ostell at 3 months), postoperative infections, adverse events, microbiological evaluation. Postoperative infections were assessed 3 days, 10 days, 1 month and 3 months after placement
Notes
Risk of bias
Item
Authors' judgement Description
Adequate sequence generation? Yes Quoted from the article: "The randomisation was performed using a random numbers table, assigning each patient to one of two treatment groups (active or placebo). Each of the enrolled patients had a patient 
